Literature DB >> 2248973

Lipogenesis in genetically diabetic (db/db) mice: developmental changes in brown adipose tissue, white adipose tissue and the liver.

P Trayhurn1, M C Wusteman.   

Abstract

Developmental changes in lipogenesis have been examined in interscapular brown adipose tissue (BAT), epididymal white adipose tissue and the liver of genetically diabetic (db/db) mice and their normal siblings. Lipogenesis was measured in vivo with 3H2O, from weaning (21 days of age) until 20 weeks of age. Hyperinsulinaemia was evident in db/db mice at all ages. Low rates of lipogenesis were observed at weaning in tissues of both groups of mice, but the rate rose rapidly in the first few days post-weaning. In normal mice, peak lipogenesis was obtained in each tissue at 4-5 weeks of age, and there were no major changes (on a whole-tissue basis) thereafter. A different developmental pattern was apparent in db/db mice. The rate of lipogenesis in BAT rose sharply after weaning, reaching a peak at 26 days of age (several times higher than normal mice), and then falling rapidly such that by 45 days of age it was lower than in normal mice; at age 20 weeks lipogenesis in BAT of the diabetic animals was negligible. In white adipose tissue of the db/db mutants lipogenesis (per tissue) reached a maximum at 5 weeks of age, and fell substantially between 10 and 20 weeks of age. Hepatic lipogenesis in the db/db mice rose progressively from weaning until 8 weeks of age, and then decreased. Except at weaning, hepatic lipogenesis (per tissue) was much greater in db/db mice than in normal mice, and the liver was a more important site of lipogenesis in diabetic mice than in normals, accounting for up to 60% of the whole-body total. In contrast, BAT accounted for a considerably smaller proportion of whole-body lipogenesis in db/db mice than in normal mice. It is concluded that there are major developmental differences in lipogenesis between tissues of db/db mice, and between diabetic and normal animals. The data suggest that there is an early and preferential development of insulin resistance in BAT of the db/db mutant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248973     DOI: 10.1016/0005-2760(90)90043-w

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Authors:  Ilya R Bederman; Gavriella Pora; Maureen O'Reilly; James Poleman; Kimberly Spoonhower; Michelle Puchowicz; Aura Perez; Bernadette O Erokwu; Alex Rodriguez-Palacios; Chris A Flask; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-17       Impact factor: 4.052

2.  ACE2 pathway regulates thermogenesis and energy metabolism.

Authors:  Xi Cao; Ting-Ting Shi; Chuan-Hai Zhang; Wan-Zhu Jin; Li-Ni Song; Yi-Chen Zhang; Jing-Yi Liu; Fang-Yuan Yang; Charles N Rotimi; Aimin Xu; Jin-Kui Yang
Journal:  Elife       Date:  2022-01-11       Impact factor: 8.140

3.  Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.

Authors:  Chong Yew Tan; Samuel Virtue; Steven Murfitt; Lee D Roberts; Lee D Robert; Yi Hui Phua; Martin Dale; Julian L Griffin; Francisco Tinahones; Philipp E Scherer; Antonio Vidal-Puig
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

4.  The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.

Authors:  Sheo B Singh; Ling Kang; Andrea R Nawrocki; Dan Zhou; Margaret Wu; Stephen Previs; Corey Miller; Haiying Liu; Catherine D G Hines; Maria Madeira; Jin Cao; Kithsiri Herath; Larry D Spears; Liangsu Wang; David E Kelley; Cai Li; Hong-Ping Guan
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.